These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6383671)

  • 1. Bone marrow transplantation and thymopoietin pentapeptide treatment in two infants with immunodeficiency with predominant T-cell defects.
    Businco L; Rossi P; Paganelli R; Galli E; DiGilio G; Lulli P; Aiuti F
    Clin Immunol Immunopathol; 1984 Oct; 33(1):123-30. PubMed ID: 6383671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy with thymopoietin pentapeptide (TP-5) in 26 patients with primary immunodeficiencies.
    Aiuti F; Businco L; Fiorilli M; Galli E; Quinti I; Le Moli S; Seminara R; Goldstein G
    Birth Defects Orig Artic Ser; 1983; 19(3):267-72. PubMed ID: 6360238
    [No Abstract]   [Full Text] [Related]  

  • 3. Improvement of natural killer activity and of T cells after thymopoietin pentapeptide therapy in a patient with severe combined immunodeficiency.
    Fiorilli M; Sirianni MC; Pandolfi F; Quinti I; Tosti U; Aiuti F; Goldstein G
    Clin Exp Immunol; 1981 Aug; 45(2):344-51. PubMed ID: 7032772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypical and functional heterogeneity of the large granular lymphocytes increased after various treatments in a patient with combined immunodeficiency.
    Takagi S; Minakuchi J; Okawa H; Yata J
    J Clin Immunol; 1989 Jan; 9(1):39-47. PubMed ID: 2649508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymopoietin pentapeptide treatment of primary immunodeficiencies.
    Aiuti F; Businco L; Fiorilli M; Galli E; Quinti I; Rossi P; Seminara R; Goldstein G
    Lancet; 1983 Mar; 1(8324):551-4. PubMed ID: 6131256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of Di George syndrome treated with thymopoietin pentapeptide (TP-5) demonstrating an adherent suppressor cell of lymphocyte function.
    Joffe MI; Sochett E; Pettifor JM; Rabson AR
    J Clin Lab Immunol; 1982 May; 8(1):69-73. PubMed ID: 6212686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymopentin (TP-5) in the treatment of the postburn and postoperative immunodeficiency syndrome.
    Hamilton G; Zöch G; Rath T; Meissl G
    Prog Clin Biol Res; 1989; 308():995-9. PubMed ID: 2528748
    [No Abstract]   [Full Text] [Related]  

  • 8. FcIgG receptor-bearing lymphocytes and monoclonal antibody-defined T cell subsets in atopic dermatitis: effect of treatment with thymopoietin pentapeptide (TP-5).
    Strannegård O; Strannegård IL; Kang K; Cooper KD; Hanifin JM
    Int Arch Allergy Appl Immunol; 1982; 69(3):238-44. PubMed ID: 6752042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Model for acquired immunodeficiency caused by anesthesia and surgical procedures. Effect of treatment with thymopoietin pentapeptide (TP5)].
    Auteri A; D'Aniello C; Falotico N; Saletti M; Di Perri T
    Recenti Prog Med; 1986 Sep; 77(9):423-8. PubMed ID: 3541085
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of synthetic thymic hormone (TP5) in children with T-cell immunodeficiencies.
    Levinsky RJ; Davies EG; Goldstein G
    Birth Defects Orig Artic Ser; 1983; 19(3):273-6. PubMed ID: 6360239
    [No Abstract]   [Full Text] [Related]  

  • 11. Usefulness of monoclonal antibodies in the diagnosis and monitoring of patients with primary immunodeficiencies: combined experience in three clinical immunology centers.
    Aiuti F; Quinti I; Seminara R; Sirianni MC; Vierucci A; Abo T; Cooper MD
    Diagn Immunol; 1983; 1(3):188-94. PubMed ID: 6388970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of thymic grafts or thymic factors to augment immunologic recovery after bone marrow transplantation: brief report with 2 to 12 years' follow-up.
    Witherspoon RP; Sullivan KM; Lum LG; Goehle S; Atkinson MK; Ochs HD; Doney KC; Hansen JA; Sanders JE; Storb R
    Bone Marrow Transplant; 1988 Sep; 3(5):425-35. PubMed ID: 3056551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymopoietin pentapeptide (TP-5) improves clinical parameters and lymphocyte subpopulations in atopic dermatitis.
    Kang K; Cooper KD; Hanifin JM
    J Am Acad Dermatol; 1983 Mar; 8(3):372-7. PubMed ID: 6339571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
    Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
    Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymopentin in dermatology.
    Haneke E
    Curr Probl Dermatol; 1989; 18():283-9. PubMed ID: 2663371
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunostimulation by TP-5 in immunocompromised patients and animals--current status of investigation.
    Waymack JP; Alexander JW
    Comp Immunol Microbiol Infect Dis; 1986; 9(2-3):225-32. PubMed ID: 3539496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results in two infants with the DiGeorge syndrome--effects of long-term TP5.
    Businco L; Rubaltelli FF; Paganelli R; Galli E; Ensoli B; Betti P; Aiuti F
    Clin Immunol Immunopathol; 1986 May; 39(2):222-30. PubMed ID: 3084141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic reconstitution with bone marrow transplantation and thymic hormones in two patients with severe pure T-cell defects.
    Businco L; Rossi P; Paganelli R; Seminara R; Aiuti F
    Birth Defects Orig Artic Ser; 1983; 19(3):281-5. PubMed ID: 6360241
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of marrow graft recipients with thymopentin.
    Witherspoon RP; Navari R; Storb R; Sullivan KM; Doney K; Beatty P; Lum LG; Thomas ED
    Bone Marrow Transplant; 1987 Apr; 1(4):365-71. PubMed ID: 3332144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of cellular function by thymopentin (TP-5) in three AIDS patients.
    Mascart-Lemone F; Huygen K; Clumeck N; Brenez D; Bolla K; Duchateau J
    Lancet; 1983 Sep; 2(8352):735-6. PubMed ID: 6193382
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.